| This week's sponsor is Premier Research. | |  | Tips for Achieving the Most Success in Acute-Pain Drug Trials
Sponsors studying treatments for acute pain boost their odds of success when they optimize conduct of early trials. Read our white paper for helpful tips on study design, assessment, and operations. Premier Research. It's what we do. Best. |
Featured Story | | | Wednesday, September 13, 2017 A drug for rare skin disease epidermolysis bullosa that Amicus Therapeutics acquired in a $847 million deal two years ago has failed a key phase 3 trial. |
|
|
| This week's sponsor is Fierce Innovation Awards. | |  | Now Accepting Applications! Deadline: Friday, October 20th
Does your product/service have the potential to transform the biotech or pharma industry? This is your chance to submit an application and have your solution reviewed by our expert panel of judges. Apply today! |
Top Stories Wednesday, September 13, 2017 Rocket Pharmaceuticals has landed a Nasdaq listing through a reverse merger. The deal will see the low-profile gene therapy startup merge with floundering Inotek Pharmaceuticals before embarking on a clutch of clinical trials. Wednesday, September 13, 2017 Early-stage California biotech BridgeBio Pharma has completed a $135 million financing round as it looks to push deeper into genetic disease R&D. Monday, September 11, 2017 When it comes to healthcare we know that consumers actively participate in social media to seek information and find support. More than 40% say that information from social media affects how they cope with a chronic condition, their approach to diet and exercise, the physician they select and even their decision to seek a second opinion. Wednesday, September 13, 2017 ProQR has spun out its CNS assets to form Amylon Therapeutics. The offshoot starts life with seed funding and an RNA-based program targeting a rare genetic disease that causes strokes. Tuesday, September 12, 2017 Age-related macular degeneration is a leading cause of vision loss in older adults but is challenging to catch early. Researchers at Massachusetts Eye and Ear have discovered a group of metabolites that could be used to improve diagnosis and treatment for AMD. Wednesday, September 13, 2017 Sanofi’s longer-acting basal insulin Toujeo, a follow-up to its own long-dominant product Lantus, beat the older drug at holding off hypoglycemia, both by day and by night. It’s an advantage Sanofi could push as it works to build up Toujeo scripts—and fights off biosimilar versions of Lantus. Resources Sponsored by: Ashfield Healthcare Join this webinar to learn how to design, deliver, and measure a successful patient support program. Presented by Nareda Mills, Ashfield's SVP of Patient Services in the US, you’ll discover how to improve adherence and improve patient outcomes using 5 key methods. Presented By: PRA Health Sciences Children participating in pediatric clinical trials are included in the contraceptive requirements applied to women of child-bearing potential, creating significant challenges for sponsors, parents, investigators and study staff. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. | 
